Dhibaatooyinka Dhibta ah ee Imuran (Azathioprine)

Waxyeellooyinka qaarkood waa in loo sheegaa dhakhtarkaaga oo xaq u leh

Maxay Imuran (Azathioprine)?

Imuran (azathioprine) waa nooc ka mid ah daawada antimetabolite ee difaaca jirka. Imuran waxaa laga yaabaa in loo qoro si loo daaweeyo xaaladaha sida cudurka calool-mareenka ee caabuqa (IBD) ama rheumatoid arthritis. Waxaa sidoo kale loo isticmaali karaa bukaanada kuwaas oo xubin ka soo qaatay xubin jidhka ka mid ah, si looga hortago jirku inuu diidmo u geysto xubnaha. Daroogadani waxay ciribtiraysaa nidaamka difaaca.

Xaaladaha badankood, Imuran waxaa loo isticmaalaa in lagu daaweeyo IBD kadib daawooyinka kale ee aan shaqayn. Waxaa sidoo kale loo isticmaali karaa wakhti isku mid ah sterids.

Daawooyinka saameeya habka difaaca jirka waxay kordhin kartaa halista infakshanka, iyo taxaddarrada loo baahan yahay in la qaado si loo ilaaliyo caabuqyada. Dadka qaadanaya Imuran waa in aysan helin wax tallaal ah oo nool. Waxa kale oo laga yaabaa inay lagama maarmaan noqoto in laga fogaado dadka jiran iyo calaamad kasta oo cudurka ah waa in dhakhtar lagala hadlo isla markiiba.

Duubka Madow

Kiniinnada Imuran waxay ku jiraan digniino madow oo la xidhiidha suurtogalnimada in la horumariyo nooc gaar ah oo kansar ah. Tani waxay khusaysaa gaar ahaan dadka qaata daroogada iyo sidoo kale waxay leeyihiin IBD. Khatarta ah in uu ku dhaco kansarka waa in la miisaamaa khatarta ah inuusan daaweynin daawada IBD.

Khatarta Kansarka ee dadka qaba IBD ayaa weli ah mawduuc socda oo loogu talagalay doodda iyo barashada, sidaas awgeed waa muhiim in la qaato hab dareen macquul ah marka la tixgelinayo halista.

Daraasadaha qaarkood waxay muujiyeen halis, laakiin qaarna ma qabaan. U hubso inaad ka wada hadashid saameyntaas saameynta xun ee dhakhtarkaaga si aad u fahamto khatartaada shakhsi ahaaneed.

Immunosuppression joogto ah oo leh IMURAN, antimetabolite purine waxay kordhisaa khatarta malignimada dadka. Warbixinnada malignimada waxaa ka mid ah lymphoma iyo hepatosplenic lymphoma (HSTCL) ee ku jira bukaanka qaba cudurrada caabuqa ee caabuqa. Dhakhaatiirta isticmaala daroogada ayaa ah inay si aad ah u yaqaanaan khatartan iyo sidoo kale kartida mutogenic ee ragga iyo dumarka labadaba iyo sunta sunatolojiga suurtogalka ah. Dhakhaatiirtu waa in ay ku wargeliyaan bukaanka khatarta maleynimada leh IMURAN.

Saamaynta Caadiga ah ee Imuran

Ka hubi dhakhtarkaaga haddii mid ka mid ah waxyeelooyinka soo socda ay sii socdaan ama ay ku dhibayaan:

Dhibaatooyinka Caadiga ah ee Caadiga ah ee Imuran

Ka hubi dhakhtarkaaga haddii mid ka mid ah waxyeelooyinka soo socda ay sii socdaan ama ay ku dhibayaan:

Had iyo jeer ogeysii dhakhtarka

Caan ka badan

In ka yar Common

In ka yar ama ka badan

Qoraalada kale:

Dhakhtarkaagu wuxuu daawan doonaa dhibaatooyinka beerka ee daawadani keeni karto.

Sababtoo ah dariiqa dawadan ayaa wax ka qabanaya jirka, waxaa jira fursad ah inay sababto waxyeelo kale oo aan la rabin oo aan dhici karin ilaa bilo ama sannado ka dib marka daawada la isticmaalo. Dhibaatooyinkaas dib u dhacani waxay ku jiri karaan noocyada kansarka qaarkood, sida leukemia, lymfoma, ama kansarka maqaarka. Khatarta kansarku way ka yar tahay dadka qaadata daawada azathioprine ee arthritis-ka, waana inaad kala hadashaa dhibaatooyinka suurtagalka ah ee dhakhtarkaaga.

Ka dib markaad joojiso dawadan, waxaa laga yaabaa in wali ay jiraan waxyaabo saameyn ah. Inta lagu jiro waqtigan u sheeg dhakhtarkaaga sida ugu dhakhsaha badan haddii aad dareento mid ka mid ah kuwan soo socda:

Waxyeellooyinka kale ee aan kor ku xusin waxay sidoo kale ku dhici kartaa bukaanjiifka qaarkood. Haddii aad aragto saameyn kale, ka hubi dhakhtarkaaga. Macluumaadkan waxaa loola jeedaa oo kaliya sida hagid - marwalba la tasho dhakhtarka ama farmashiistaha macluumaadka dhamaystiran ee ku saabsan daawooyinka laguu qoray.

Xigasho:

Prometheus Laboratories Inc. " Imuran (azathioprine) Warbixinta Qorista ." FDA.gov. Feb 2014..

Armstrong RG, West J, Card TR. "Halista kansarka ku dhaca cudurka mindhicirka ee caabuqsan ayaa lagu daaweeyaa daawada azathioprine. Am J Gastroenterol . 2010 Jul; 105 (7): 1604-1609.